Agency Forms Undergoing Paperwork Reduction Act Review, 34705-34706 [2011-14422]
Download as PDF
<![CDATA[
Federal Register / Vol. 76, No. 114 / Tuesday, June 14, 2011 / Notices
srobinson on DSK4SPTVN1PROD with NOTICES
FOR FURTHER INFORMATION CONTACT:
Benish Shah, Office of Managing
Director, (202) 418–7866.
SUPPLEMENTARY INFORMATION:
OMB Control No.: 3060–0532.
Title: Sections 2.1033 and 15.121,
Scanning Receiver Compliance Exhibits.
Form No.: N/A.
Type of Review: Extension of a
currently approved collection.
Respondents: Business or other forprofit.
Number of Respondents: 25
respondents; 25 responses.
Estimated Time per Response: 1 hour.
Frequency of Response: One time
reporting requirement and third party
disclosure requirement.
Obligation to Respond: Required to
obtain or retain benefits. The statutory
authority for this information collection
is contained in 47 U.S.C. Sections
154(i), 301, 302, 303(e), 303(f), 303(g),
303(r), 304 and 307.
Total Annual Burden: 25 hours.
Annual Cost Burden: $1,250.
Privacy Act Impact Assessment: N/A.
Nature and Extent of Confidentiality:
The Commission’s rules require that
certain portions of scanning receiver
applications for certification will remain
confidential after the effective date of
the grant of the application. No other
assurances of confidentiality are
provided to respondents.
Needs and Uses: This collection will
be submitted as an extension (no change
in reporting and/or third party
disclosure requirements) after this 60day comment period to the Office of
Management and Budget (OMB) in order
to obtain the full three year clearance.
The FCC rules under 47 CFR 2.1033
and 15.121 require manufacturers of
scanning receivers to design their
equipment so that it has 38 dB of image
rejection for Cellular Service
frequencies, tuning, control and filtering
circuitry are inaccessible and any
attempt to modify the scanning receiver
to receive Cellular Service transmissions
will likely render the scanning receiver
inoperable. The Commission’s rules also
require manufacturers to submit
information with any application for
certification that describes the testing
method used to determine compliance
with the 38 dB image rejection ratio, the
design features that prevent
modification of the scanning receiver to
receive Cellular Service transmissions,
and the design steps taken to make
tuning, control, and filtering circuitry
inaccessible. Furthermore, the FCC
requires equipment to carry a statement
assessing the vulnerability of the
scanning receiver to modification and to
have a label affixed to the scanning
VerDate Mar<15>2010
16:27 Jun 13, 2011
Jkt 223001
receiver, similar to the following as
described in section 15.121:
Warning: Modification of this device
to receive cellular radiotelephone
service signals is prohibited under FCC
Rules and Federal Law.
The Commission uses the information
required in this equipment
authorization process to determine
whether the equipment that is being
marketed complies with the
Congressional mandate in the
Telephone Disclosure and Dispute
Resolution Act of 1992 (TDDRA) and
applicable Commission rules.
Federal Communications Commission.
Marlene H. Dortch,
Secretary, Office of the Secretary, Office of
Managing Director.
[FR Doc. 2011–14642 Filed 6–13–11; 8:45 am]
BILLING CODE 6712–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–11–11DD]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an
e-mail to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
Focus Group Study for Raising Public
Awareness of Deep Vein Thrombosis/
Pulmonary Embolism—New—National
Center on Birth Defects and
Developmental Disabilities (NCBDDD),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The Division of Blood Disorders,
located within the National Center on
Birth Defects and Developmental
Disabilities, implements health
promotion and wellness programs
designed to prevent secondary
conditions in people with bleeding and
clotting disorders.
There are few public health problems
as serious as deep vein thrombosis
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
34705
(DVT) and pulmonary embolism (PE),
yet these conditions receive little
attention. DVT/PE is an
underdiagnosed, serious, preventable
medical condition that occurs when a
blood clot forms in a deep vein. These
clots usually develop in the lower leg,
thigh, or pelvis, but they can also occur
in the arm. In more than one third of
people affected by DVT, clots can travel
to the lungs and cause PE, a potentially
fatal condition.
The precise number of people affected
by DVT/PE is unknown, but estimates
range from 300,000 to 600,000 annually
in the United States. DVT/PE is
associated with substantial morbidity
and mortality: One third of people with
DVT/PE will have a recurrence within
10 years and one third of people die
within 1 month of diagnosis. Among
people who have had a DVT, one third
will have long-term complications (postthrombotic syndrome), such as swelling,
pain, discoloration, and scaling in the
affected limb. In some cases, the
symptoms can be so severe that a person
can become disabled. More troubling,
sudden death is the first symptom in
about one quarter of people who have a
PE.
The Division of Blood Disorders
submitted questions to the 2007
HealthStyles survey to determine the
public’s knowledge of DVT, its common
symptoms, and risk factors. Although
over 60% of respondents identified pain
and swelling as symptoms, 60% did not
identify tenderness (often the first sign
of DVT) as a symptom. Only 38% of
respondents knew that a DVT was a
blood clot in a vein, and most could not
identify common risk factors for DVT
such as sitting for a long period of time
(e.g., during air travel); having a leg or
foot injury; having a family member
who has had a DVT; taking birth control
pills; or getting older; and certain
groups could not identify risk factors
that specifically applied to their risk.
The results of this survey demonstrate
the need for greater awareness of DVT
and its risk factors and the data show
that there are many opportunities to
develop audience specific messages that
are age specific and culturally
appropriate.
Much of the morbidity and mortality
associated with DVT/PE could be
prevented with early and accurate
diagnosis and management. DVT/PE is
preventable. It is important for people to
be able to recognize the signs and
symptoms and know when to seek care
and available treatment. Individuals,
families, and their support communities
can reduce their risk by understanding
DVT/PE and its risk factors. DVT/PE
affects people of all races and ages.
E:\FR\FM\14JNN1.SGM
14JNN1
34706
Federal Register / Vol. 76, No. 114 / Tuesday, June 14, 2011 / Notices
Many of the acquired risks such as
obesity, advanced age, air travel,
chronic diseases, cancer, and
hospitalization are increasing in the
United States, and we can expect to see
increasing numbers of people affected
by DVT/PE.
The CDC’s Division of Blood
Disorders will conduct focus groups to
develop messaging concepts that will be
used in a public awareness campaign to
build knowledge and awareness of DVT/
PE, increase recognition of the
symptoms and risk factors for DVT/PE,
and empower people to take action.
The project will address these
objectives in two stages: in the first stage
the Contractor selected will conduct
eight (8) formative focus groups with
nine (9) participants in each focus group
to explore consumer knowledge,
attitudes, and beliefs (KABs) toward
DVT. Message concepts will be
developed from insights emerging from
this exploratory research phase. The
Contractor will conduct eight (8) focus
groups with nine (9) participants in
each focus group during the second
stage to test the message concepts and
identify possible ways to present the
messages.
The Contractor selected will work
with CDC to identify and recruit focus
group participants. Formative research
participants will include adults (aged
25–64) who have been hospitalized in
the last year and seniors (aged 65–80).
Message testing participants will
include adults (aged 25–64) who have
been hospitalized in the last year and
seniors (aged 65–80). Participants will
be recruited to participate in one of
sixteen in-person focus groups that will
be conducted in the following cities:
• Atlanta, Baltimore, Pittsburgh, and
Tampa (formative research task), and
• Atlanta, Baltimore, Pittsburgh, and
Tampa (message testing task).
It is estimated that a total of 144
respondents will have to be screened in
order to recruit 36 focus group
participants for each year. There are no
costs to the respondents other than their
time. The estimated annualized burden
hours are 125.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Average
burden per
response
(in hours)
Number responses per
respondent
Type of respondent
Form name
Seniors (65–80) ..............................................
Adults (25–64) recently hospitalized
Seniors (65–80) ..............................................
Adults (25–64) recently hospitalized
Seniors (65–80) ..............................................
Participant Screener .......................................
144
1
5/60
Participant Re-screener .................................
36
1
9/60
Moderator’s Guide:
Focus Groups.
Research
36
1
1.5
Moderator’s Guide: Message Testing Focus
Groups.
36
1
1.5
Informed Consent Form .................................
36
1
6/60
Adults (25–64) recently hospitalized
Seniors (65–80) ..............................................
Adults (25–64) recently hospitalized
Seniors (65–80) ..............................................
Adults (25–64) recently hospitalized
Dated: June 3, 2011.
Daniel L. Holcomb,
Reports Clearance Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2011–14422 Filed 6–13–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket Number CDC–2011–0006]
[RIN 0920–ZA03]
Privacy Act of 1974; System of
Records
Department of Health and
Human Services (HHS), Centers for
Disease Control and Prevention (CDC),
National Institute for Occupational
Safety and Health (NIOSH).
ACTION: Notification of proposed altered
system of records; clarification.
srobinson on DSK4SPTVN1PROD with NOTICES
AGENCY:
On May 27, 2011, the Centers
for Disease Control and Prevention
SUMMARY:
VerDate Mar<15>2010
16:27 Jun 13, 2011
Jkt 223001
Formative
(CDC), located within the Department of
Health and Human Services (HHS),
published a Notification of Proposed
Altered System of Records for its system
of records, 09–20–0147, ‘‘Occupational
Health Epidemiological Studies and
EEOICPA Program Records, HHS/CDC/
NIOSH.’’ This document offers
clarifications to the May publication.
DATES: Comments must be received on
or before June 27, 2011.
ADDRESSES: You may submit written
comments, identified by the Privacy Act
System of Records Number 09–20–0147,
to the following address: HHS/CDC
Senior Official for Privacy (SOP), Office
of the Chief Information Security Officer
(OCISO), 4770 Buford Highway—M/S:
F–35, Atlanta, GA 30341.
You may also submit written
comments electronically to https://
www.regulations.gov. Comments must
be identified by Docket No. CDC–2011–
0006. Please follow directions at
https://www.regulations.gov to submit
comments.
All relevant comments received will
be posted publicly to https://
www.regulations.gov without change,
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
including any personal or proprietary
information provided. An electronic
version of the draft is available to
download at https://
www.regulations.gov.
Written comments, identified by
Docket No. CDC–2011–0006, and/or
Privacy Act System of Records Number
09–20–0147, will be available for public
inspection Monday through Friday,
except for legal holidays, from 9 a.m.
until 3 p.m., Eastern Daylight Time, at
4770 Buford Highway—M/S: F–35,
Atlanta, GA 30341. Please call ahead to
(770) 488–8660, and ask for a
representative from Office of the Chief
Information Security Officer (OCISO) to
schedule your visit. Comments may also
be viewed at https://
www.regulations.gov.
FOR FURTHER INFORMATION CONTACT:
Beverly E. Walker, Chief Privacy Officer,
Centers for Disease Control and
Prevention, 4770 Buford Highway—M/
S: F–35, Atlanta, Georgia 30341, (770)
488–8660. This is not a toll-free number.
SUPPLEMENTARY INFORMATION: In the May
27, 2011, notice (76 FR 31212), CDC
provided information regarding the
E:\FR\FM\14JNN1.SGM
14JNN1
]]>Agencies
[Federal Register Volume 76, Number 114 (Tuesday, June 14, 2011)]
[Notices]
[Pages 34705-34706]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-14422]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-11-11DD]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail
to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of
Management and Budget, Washington, DC or by fax to (202) 395-5806.
Written comments should be received within 30 days of this notice.
Proposed Project
Focus Group Study for Raising Public Awareness of Deep Vein
Thrombosis/Pulmonary Embolism--New--National Center on Birth Defects
and Developmental Disabilities (NCBDDD), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The Division of Blood Disorders, located within the National Center
on Birth Defects and Developmental Disabilities, implements health
promotion and wellness programs designed to prevent secondary
conditions in people with bleeding and clotting disorders.
There are few public health problems as serious as deep vein
thrombosis (DVT) and pulmonary embolism (PE), yet these conditions
receive little attention. DVT/PE is an underdiagnosed, serious,
preventable medical condition that occurs when a blood clot forms in a
deep vein. These clots usually develop in the lower leg, thigh, or
pelvis, but they can also occur in the arm. In more than one third of
people affected by DVT, clots can travel to the lungs and cause PE, a
potentially fatal condition.
The precise number of people affected by DVT/PE is unknown, but
estimates range from 300,000 to 600,000 annually in the United States.
DVT/PE is associated with substantial morbidity and mortality: One
third of people with DVT/PE will have a recurrence within 10 years and
one third of people die within 1 month of diagnosis. Among people who
have had a DVT, one third will have long-term complications (post-
thrombotic syndrome), such as swelling, pain, discoloration, and
scaling in the affected limb. In some cases, the symptoms can be so
severe that a person can become disabled. More troubling, sudden death
is the first symptom in about one quarter of people who have a PE.
The Division of Blood Disorders submitted questions to the 2007
HealthStyles survey to determine the public's knowledge of DVT, its
common symptoms, and risk factors. Although over 60% of respondents
identified pain and swelling as symptoms, 60% did not identify
tenderness (often the first sign of DVT) as a symptom. Only 38% of
respondents knew that a DVT was a blood clot in a vein, and most could
not identify common risk factors for DVT such as sitting for a long
period of time (e.g., during air travel); having a leg or foot injury;
having a family member who has had a DVT; taking birth control pills;
or getting older; and certain groups could not identify risk factors
that specifically applied to their risk. The results of this survey
demonstrate the need for greater awareness of DVT and its risk factors
and the data show that there are many opportunities to develop audience
specific messages that are age specific and culturally appropriate.
Much of the morbidity and mortality associated with DVT/PE could be
prevented with early and accurate diagnosis and management. DVT/PE is
preventable. It is important for people to be able to recognize the
signs and symptoms and know when to seek care and available treatment.
Individuals, families, and their support communities can reduce their
risk by understanding DVT/PE and its risk factors. DVT/PE affects
people of all races and ages.
[[Page 34706]]
Many of the acquired risks such as obesity, advanced age, air travel,
chronic diseases, cancer, and hospitalization are increasing in the
United States, and we can expect to see increasing numbers of people
affected by DVT/PE.
The CDC's Division of Blood Disorders will conduct focus groups to
develop messaging concepts that will be used in a public awareness
campaign to build knowledge and awareness of DVT/PE, increase
recognition of the symptoms and risk factors for DVT/PE, and empower
people to take action.
The project will address these objectives in two stages: in the
first stage the Contractor selected will conduct eight (8) formative
focus groups with nine (9) participants in each focus group to explore
consumer knowledge, attitudes, and beliefs (KABs) toward DVT. Message
concepts will be developed from insights emerging from this exploratory
research phase. The Contractor will conduct eight (8) focus groups with
nine (9) participants in each focus group during the second stage to
test the message concepts and identify possible ways to present the
messages.
The Contractor selected will work with CDC to identify and recruit
focus group participants. Formative research participants will include
adults (aged 25-64) who have been hospitalized in the last year and
seniors (aged 65-80). Message testing participants will include adults
(aged 25-64) who have been hospitalized in the last year and seniors
(aged 65-80). Participants will be recruited to participate in one of
sixteen in-person focus groups that will be conducted in the following
cities:
Atlanta, Baltimore, Pittsburgh, and Tampa (formative
research task), and
Atlanta, Baltimore, Pittsburgh, and Tampa (message testing
task).
It is estimated that a total of 144 respondents will have to be
screened in order to recruit 36 focus group participants for each year.
There are no costs to the respondents other than their time. The
estimated annualized burden hours are 125.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number burden per
Type of respondent Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Seniors (65-80).................... Participant Screener....... 144 1 5/60
Adults (25-64) recently
hospitalized
Seniors (65-80).................... Participant Re-screener.... 36 1 9/60
Adults (25-64) recently
hospitalized
Seniors (65-80).................... Moderator's Guide: 36 1 1.5
Formative Research Focus
Groups.
Adults (25-64) recently
hospitalized
Seniors (65-80).................... Moderator's Guide: Message 36 1 1.5
Testing Focus Groups.
Adults (25-64) recently
hospitalized
Seniors (65-80).................... Informed Consent Form...... 36 1 6/60
Adults (25-64) recently
hospitalized
----------------------------------------------------------------------------------------------------------------
Dated: June 3, 2011.
Daniel L. Holcomb,
Reports Clearance Officer, Centers for Disease Control and Prevention.
[FR Doc. 2011-14422 Filed 6-13-11; 8:45 am]
BILLING CODE 4163-18-P
